Trevena, Inc. revenue for the last year amounted to 3.12 M USD, the most of which — 3.12 M USD — came from its highest performing source at the moment, Novel Medicines for Central Nervous System Disorders, the year earlier bringing -418.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Trevena, Inc. 3.12 M USD, and the year before that — -418.00 k USD.